Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX
$19.45
-2.51%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-11-09 | View → |
| 8-K | 8-K | 2026-11-03 | View → |
| 4 | FORM 4 | 2026-09-21 | View → |
| 4 | FORM 4 | 2026-09-14 | View → |
| 4 | FORM 4 | 2026-09-02 | View → |
| 4 | FORM 4 | 2026-08-25 | View → |
| 4 | FORM 4 | 2026-08-14 | View → |
| 4 | FORM 4 | 2026-08-13 | View → |
| 4 | FORM 4 | 2026-08-13 | View → |
| 4 | FORM 4 | 2026-08-13 | View → |
| 4 | FORM 4 | 2026-08-12 | View → |
| 4 | FORM 4 | 2026-08-12 | View → |
| 4 | FORM 4 | 2026-08-12 | View → |
| 4 | FORM 4 | 2026-08-12 | View → |
| 8-K | 8-K | 2026-08-10 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-03 | View → |
| 8-K | 8-K | 2026-07-31 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 4 | FORM 4 | 2026-05-12 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| 8-K | 8-K | 2026-04-22 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2026-03-25 | View → |
| 4 | FORM 4 | 2026-03-05 | View → |
| 4 | FORM 4 | 2026-03-05 | View → |
| 4 | FORM 4 | 2026-03-05 | View → |
| 4 | FORM 4 | 2026-03-05 | View → |
| 4 | FORM 4 | 2026-03-05 | View → |
| 4 | FORM 4 | 2026-03-05 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $19.45
- Market Cap
- $6.95 billion
- 52-Week Range
- $9.56 – $21.68
- Average Volume
- 4.13 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.